China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE: 300294)
China
· Delayed Price · Currency is CNY 33.68
+0.40 (1.20%)
Sep 9, 2024, 12:49 PM CST
China Resources Boya Bio-pharmaceutical Group Co.,Ltd Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 2,006 | 2,651 | 2,761 | 2,645 | 2,510 | 2,907 | Upgrade
|
| Other Revenue | 0.8 | 0.85 | -2.22 | 5.21 | 3.36 | 2.01 | Upgrade
|
| Revenue | 2,007 | 2,652 | 2,759 | 2,651 | 2,513 | 2,909 | Upgrade
|
| Revenue Growth (YoY) | -30.82% | -3.87% | 4.08% | 5.47% | -13.60% | 21.83% | Upgrade
|
| Cost of Revenue | 782.38 | 1,259 | 1,255 | 1,187 | 1,055 | 1,126 | Upgrade
|
| Gross Profit | 1,224 | 1,393 | 1,504 | 1,463 | 1,458 | 1,783 | Upgrade
|
| Selling, General & Admin | 627.02 | 774.85 | 923.64 | 969.52 | 1,039 | 1,140 | Upgrade
|
| Research & Development | 60.31 | 67.7 | 49.58 | 59.29 | 89.05 | 92.76 | Upgrade
|
| Other Operating Expenses | 26.88 | 14.31 | 20.83 | 19.99 | 8.93 | 21.07 | Upgrade
|
| Operating Expenses | 719.61 | 859.23 | 996.86 | 1,049 | 1,128 | 1,260 | Upgrade
|
| Operating Income | 504.86 | 534.05 | 507.16 | 414.49 | 330.18 | 522.72 | Upgrade
|
| Interest Expense | -0.28 | -0.46 | -0.62 | -10.53 | -21.45 | -30.76 | Upgrade
|
| Interest & Investment Income | 45.63 | 45.31 | 64.93 | 63.9 | 22.96 | 14.06 | Upgrade
|
| Other Non Operating Income (Expenses) | 86.67 | 85.31 | 4.02 | -8.3 | -3.07 | -2.24 | Upgrade
|
| EBT Excluding Unusual Items | 636.88 | 664.21 | 575.49 | 459.57 | 328.63 | 503.79 | Upgrade
|
| Impairment of Goodwill | -298.41 | -298.41 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -20.13 | - | - | 10.71 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.98 | 1.3 | 0.07 | -0.87 | -1.58 | 1.44 | Upgrade
|
| Asset Writedown | -27.84 | -28.31 | -51.03 | -36.37 | -0.27 | -0.19 | Upgrade
|
| Other Unusual Items | 36.49 | 14.92 | 7.47 | 10.08 | 1.36 | 15 | Upgrade
|
| Pretax Income | 327.97 | 353.71 | 532 | 443.12 | 328.13 | 520.04 | Upgrade
|
| Income Tax Expense | 96.75 | 105.56 | 86.51 | 84.84 | 52.87 | 77.92 | Upgrade
|
| Earnings From Continuing Operations | 231.22 | 248.15 | 445.49 | 358.28 | 275.26 | 442.12 | Upgrade
|
| Minority Interest in Earnings | -3.71 | -10.68 | -13.29 | -13.75 | -15.2 | -15.98 | Upgrade
|
| Net Income | 227.52 | 237.47 | 432.2 | 344.53 | 260.06 | 426.15 | Upgrade
|
| Net Income to Common | 227.52 | 237.47 | 432.2 | 344.53 | 260.06 | 426.15 | Upgrade
|
| Net Income Growth | -52.53% | -45.06% | 25.45% | 32.48% | -38.97% | -9.17% | Upgrade
|
| Shares Outstanding (Basic) | 505 | 505 | 503 | 436 | 426 | 426 | Upgrade
|
| Shares Outstanding (Diluted) | 505 | 505 | 503 | 436 | 426 | 426 | Upgrade
|
| Shares Change (YoY) | 1.11% | 0.54% | 15.24% | 2.30% | 0.04% | 0.82% | Upgrade
|
| EPS (Basic) | 0.45 | 0.47 | 0.86 | 0.79 | 0.61 | 1.00 | Upgrade
|
| EPS (Diluted) | 0.45 | 0.47 | 0.86 | 0.79 | 0.61 | 1.00 | Upgrade
|
| EPS Growth | -53.05% | -45.35% | 8.86% | 29.51% | -39.00% | -9.91% | Upgrade
|
| Free Cash Flow | 376.22 | 554.23 | 458.03 | 1,277 | 576.07 | -203.13 | Upgrade
|
| Free Cash Flow Per Share | 0.74 | 1.10 | 0.91 | 2.93 | 1.35 | -0.48 | Upgrade
|
| Dividend Per Share | 0.300 | 0.300 | 0.200 | 0.150 | 0.065 | 0.150 | Upgrade
|
| Dividend Growth | 50.00% | 50.00% | 33.33% | 130.77% | -56.67% | -1.62% | Upgrade
|
| Gross Margin | 61.01% | 52.54% | 54.52% | 55.21% | 58.01% | 61.29% | Upgrade
|
| Operating Margin | 25.16% | 20.14% | 18.38% | 15.64% | 13.14% | 17.97% | Upgrade
|
| Profit Margin | 11.34% | 8.95% | 15.67% | 13.00% | 10.35% | 14.65% | Upgrade
|
| Free Cash Flow Margin | 18.75% | 20.90% | 16.60% | 48.19% | 22.92% | -6.98% | Upgrade
|
| EBITDA | 592.88 | 626.18 | 600.38 | 510.65 | 411.52 | 605.49 | Upgrade
|
| EBITDA Margin | 29.54% | 23.61% | 21.76% | 19.27% | 16.38% | 20.82% | Upgrade
|
| D&A For EBITDA | 88.02 | 92.13 | 93.22 | 96.16 | 81.34 | 82.77 | Upgrade
|
| EBIT | 504.86 | 534.05 | 507.16 | 414.49 | 330.18 | 522.72 | Upgrade
|
| EBIT Margin | 25.16% | 20.14% | 18.38% | 15.64% | 13.14% | 17.97% | Upgrade
|
| Effective Tax Rate | 29.50% | 29.84% | 16.26% | 19.15% | 16.11% | 14.98% | Upgrade
|
| Revenue as Reported | 2,007 | 2,652 | 2,759 | 2,651 | - | 2,909 | Upgrade
|
| Advertising Expenses | - | 2.73 | 1.82 | 2.5 | 1.77 | 0.74 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.